Drug Shortage Report for TOVIAZ
| Report ID | 158318 |
| Drug Identification Number | 02380048 |
| Brand name | TOVIAZ |
| Common or Proper name | Toviaz |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | FESOTERODINE FUMARATE |
| Strength(s) | 8MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 1x30 BTL |
| ATC code | G04BD |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-05-30 |
| Actual start date | 2022-05-26 |
| Estimated end date | 2022-09-30 |
| Actual end date | 2022-09-30 |
| Shortage status | Resolved |
| Updated date | 2022-10-01 |
| Company comments | Toviaz 4mg remains available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2022-10-01 | English | Compare |
| v17 | 2022-09-30 | French | Compare |
| v16 | 2022-09-30 | English | Compare |
| v15 | 2022-09-08 | French | Compare |
| v14 | 2022-09-08 | English | Compare |
| v13 | 2022-09-08 | French | Compare |
| v12 | 2022-09-08 | English | Compare |
| v11 | 2022-07-11 | French | Compare |
| v10 | 2022-07-11 | English | Compare |
| v9 | 2022-06-15 | French | Compare |
| v8 | 2022-06-15 | English | Compare |
| v7 | 2022-05-27 | French | Compare |
| v6 | 2022-05-27 | English | Compare |
| v5 | 2022-05-11 | French | Compare |
| v4 | 2022-05-11 | English | Compare |
| v3 | 2022-05-11 | English | Compare |
| v2 | 2022-04-07 | French | Compare |
| v1 | 2022-04-07 | English | Compare |
Showing 1 to 18 of 18